151 related articles for article (PubMed ID: 21843188)
1. Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder.
Leggett C; Hotham E
J Paediatr Child Health; 2011 Aug; 47(8):512-7. PubMed ID: 21843188
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
4. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.
Johnston C; Seipp C; Hommersen P; Hoza B; Fine S
Child Care Health Dev; 2005 Nov; 31(6):669-77. PubMed ID: 16207224
[TBL] [Abstract][Full Text] [Related]
5. Management of attention deficit hyperactivity disorder: a parental perspective.
Concannon PE; Tang YP
J Paediatr Child Health; 2005 Dec; 41(12):625-30. PubMed ID: 16398864
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
7. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
[TBL] [Abstract][Full Text] [Related]
8. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
9. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
10. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
[TBL] [Abstract][Full Text] [Related]
11. [Attention deficit disorder: multidisciplinary observational study over 1 year].
Chambry J; Billard C; Guinard M; Lacaze E; Idiart ME; Delteil-Pinton F; Cohen de Lara A
Encephale; 2011 Jun; 37(3):180-90. PubMed ID: 21703433
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
13. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Findling RL; Short EJ; Manos MJ
J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
15. [The clinical semiology of attention deficit hyperactivity disorder according to age, and the effectiveness of treatments at different ages].
García-Pérez A; Expósito-Torrejón J; Martínez-Granero MA; Quintanar-Rioja A; Bonet-Serra B
Rev Neurol; 2005 Nov 1-15; 41(9):517-24. PubMed ID: 16254857
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children.
Hazell PL; Stuart JE
J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):886-94. PubMed ID: 12874489
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
18. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
Thorell LB; Dahlström K
J Atten Disord; 2009 Mar; 12(5):460-8. PubMed ID: 18685139
[TBL] [Abstract][Full Text] [Related]
19. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
20. Parent-assisted transfer of children's social skills training: effects on children with and without attention-deficit hyperactivity disorder.
Frankel F; Myatt R; Cantwell DP; Feinberg DT
J Am Acad Child Adolesc Psychiatry; 1997 Aug; 36(8):1056-64. PubMed ID: 9256585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
